MedPath
Found 14 clinical trials|View Analysis
Sort by:

Study to Assess the Safety and Immunogenicity of a Single Dose of GlaxoSmithKline's (GSK) Meningococcal MenACWY-CRM Vaccine (Menveo), Administered to Subjects 15 Through 55 Years of Age, Approximately 4-6 Years After Primary ACWY Vaccination

Phase 3
Completed
Conditions
Infections, Meningococcal
Interventions
Biological: Meningococcal (groups A, C, W and Y) oligosaccharide diphtheria CRM-197 conjugate Vaccine (Menveo)
First Posted Date
2016-12-08
Last Posted Date
2019-11-25
Lead Sponsor
GlaxoSmithKline
Target Recruit Count
704
Registration Number
NCT02986854
Locations
🇵🇷

GSK Investigational Site, Ponce, Puerto Rico

Understanding the Immune Response to Two Different Meningitis Vaccines

Phase 4
Completed
Conditions
Meningococcal Disease
Septicaemia
Meningitis
Interventions
Biological: MenACWY-CRM conjugate vaccine (Menveo, Novartis)
Biological: MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis)
Biological: Polysaccharide (subcutaneously)-conjugate
Biological: 1/5th dose MenACWY-PS polysaccharide vaccine, ( ACWYVax, GSK) and MenACWY-CRM conjugate vaccine (Menveo, Novartis)
First Posted Date
2012-05-08
Last Posted Date
2016-11-30
Lead Sponsor
University of Oxford
Target Recruit Count
20
Registration Number
NCT01593514
Locations
🇬🇧

Oxford Vaccine Group, Oxford, Oxfordshire, United Kingdom

A Phase 3b, Randomized, Open-Label Study to Evaluate the Safety and Immunogenicity of Select Travel Vaccines When Administered Concomitantly With MenACWY in Adults

Phase 3
Completed
Conditions
Meningococcal Meningitis
Typhoid
Japanese Encephalitis
Meningococcal Disease
Yellow Fever
Rabies
Interventions
Biological: Rabies Vaccine
Biological: Typhoid Vi Polysaccharide Vaccine
Biological: Japanese Encephalitis Vaccine
Biological: Yellow Fever Vaccine
Biological: MenACWY-CRM Vaccine
First Posted Date
2011-11-08
Last Posted Date
2014-03-11
Lead Sponsor
Novartis
Target Recruit Count
552
Registration Number
NCT01466387
Locations
🇨🇿

Centrum ockovani a cestovni mediciny (Vaccination and Travel Medicine Centre) Poliklinika II, Bratri Stefanu 895, Hradec Kralove, Czech Republic

🇩🇪

University of Munich Georgenstr.5, Muenchen, Germany

🇩🇪

Berliner Centrum Fur Reise und Tropenmedizin, Jaegerstrasse 67-69, Berlin, Germany

and more 1 locations

Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine

Phase 3
Completed
Conditions
Hepatitis A
Hepatitis B
Meningococcal Disease
Meningococcal Meningitis
Interventions
Biological: MenACWY-CRM
Biological: Combined inactivated hepatitis A & recombinant hepatitis B
Biological: Recombinant hepatitis B vaccine
Biological: Inactivated hepatitis A vaccine
First Posted Date
2011-10-17
Last Posted Date
2017-06-08
Lead Sponsor
Novartis Vaccines
Target Recruit Count
252
Registration Number
NCT01453348
Locations
🇩🇪

04, Novartis Investigational Site, Rostock, Germany

🇩🇪

03, Novartis Investigational Site, Berlin, Germany

🇩🇪

02, Novartis Investigational Site, Hamburg, Germany

and more 1 locations

Safety Surveillance of MenACWY-CRM Vaccine in Children

Completed
Conditions
Meningococcal Disease
Interventions
Biological: MenACWY-CRM
First Posted Date
2011-10-14
Last Posted Date
2015-08-06
Lead Sponsor
Novartis Vaccines
Target Recruit Count
393
Registration Number
NCT01452438
Locations
🇺🇸

Kaiser Permanente South California, Pasadena, California, United States

A Phase 4, Placebo-Controlled, Randomized Study to Evaluate the Immunogenicity and Safety of HPV and Tdap When Administered With MenACWY in Adolescents

Phase 4
Completed
Conditions
Meningococcal Meningitis
Interventions
Biological: Placebo + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus Vaccine
Biological: MenACWY-CRM Conjugate Vaccine + Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine + Quadrivalent Human Papillomavirus Vaccine
First Posted Date
2011-08-29
Last Posted Date
2014-02-14
Lead Sponsor
Novartis
Target Recruit Count
801
Registration Number
NCT01424644
Locations
🇺🇸

Prairie Fields Family Medicine, 350 W. 23rd Street, Suite A, Fremont, California, United States

🇮🇹

HOSPITAL"SAN MARTINO". Department of Health Sciences University of Genoa, Via Pastore, 1, Genoa, Italy

🇺🇸

Clinical Research Advantage / Colorado Springs Health Partners, 6340 Barnes Road, Colorado Springs, Colorado, United States

and more 17 locations

Novartis Vaccine and Diagnostics Carriage Trial

Phase 3
Completed
Conditions
N. Meningitidis Carriage
Interventions
Biological: MenACWY-CRM conjugate vaccine
Biological: Japanese Encephalitis vaccine
Biological: Meningococcal B Recombinant + Outer Membrane Vesicle vaccine (rMenB+OMV NZ)
First Posted Date
2010-10-05
Last Posted Date
2016-04-21
Lead Sponsor
Novartis Vaccines
Target Recruit Count
2968
Registration Number
NCT01214850
Locations
🇬🇧

Bristol Children's Vaccine Center, University of Bristol,, Bristol, England, United Kingdom

🇬🇧

Royal Liverpool and Broad Green University Hospital Trust, Liverpool, England, United Kingdom

🇬🇧

St Georges Vaccine Institute, St Georges, University of London, London, England, United Kingdom

and more 7 locations

A Study to Evaluate the Persistence and Immune Response to a Booster Dose of MenACWY

Phase 2
Completed
Conditions
Meningococcal Disease
Meningococcal Meningitis
Interventions
Biological: Novartis Meningococcal (MenACWY-CRM) vaccine
First Posted Date
2009-11-25
Last Posted Date
2015-07-15
Lead Sponsor
Novartis Vaccines
Target Recruit Count
155
Registration Number
NCT01018732

Evaluation of Persistence of Anti-meningococcal Bactericidal Antibodies Among Adolescents Who Previously Received MenACWY Conjugate Vaccine

Phase 3
Completed
Conditions
Meningococcal Meningitis
Interventions
Biological: MenACWY-CRM conjugate vaccine
Biological: Licensed comparator
First Posted Date
2009-03-05
Last Posted Date
2017-06-14
Lead Sponsor
Novartis Vaccines
Target Recruit Count
389
Registration Number
NCT00856297
Locations
🇺🇸

23 Pediatric Associates of Latrobe 210 Weldon Street, Latrobe, Pennsylvania, United States

🇺🇸

PEAK Research, LLC, 2589 Washington Road, Suite 412B, Upper Saint Clair, Pennsylvania, United States

🇺🇸

8 Kaiser Permanente Hayward 27303 Sleepy Hollow Ave., 1st Floor, MOB, Hayward, California, United States

and more 29 locations

Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers

Phase 3
Completed
Conditions
Meningococcal Infections
Interventions
Biological: MenACWY-CRM + MMRV
Biological: MMRV
Biological: MenACWY-CRM
First Posted Date
2008-02-29
Last Posted Date
2013-04-19
Lead Sponsor
Novartis Vaccines
Target Recruit Count
1630
Registration Number
NCT00626327
Locations
🇺🇸

Site 39 - Pediatric Associates of Fall River, 829 S. Main Street, Fall River, Massachusetts, United States

🇺🇸

Site 80 - The Children's Clinic of Jonesboro, 800 S. Church St; Suite 400; 4th Fl, Jonesboro, Arkansas, United States

🇺🇸

Site 25 - Kentucky Pediatric/ Adult Research 201 South 5th Street Suite 102, Bardstown, Kentucky, United States

and more 87 locations
© Copyright 2025. All Rights Reserved by MedPath